Breaking
•IHG Says It’s Winning Hotels From Rival Brands•First human case of livestock virus Shamonda unlikely to lead to wider spread, WHO says - Reuters•Kratom Is an Opioid, Doctor Argues•Video Decision Aid Boosts Advance Care Planning in Late-Stage Kidney Disease•Milestone Moment With Grupo Duelo | Billboard Latin Music Week 2026•Forest Hills Stadium Agrees to Cap Number of Concerts Per Year, Ending Years of Litigation With Locals•James Bond Final Screen Tests Are Happening This Week•‘Tangles’ Wins Grand Jury Prize at Animation Is Film Festival•Telangana to host three-day Raksha Expo from December 7•Kerala High Court upholds 10-year jail term for man convicted of raping 73-year-old woman•Tirupati MP alleges NDA ‘coercion’ against YSRCP nominees, seeks SEC action•Kering’s revenues hit by drop in sales at flagship brand Gucci•BREAKING: Alabama Crimson Tide LOSING Key Players at WORST TIME—Is the SEASON ON THE BRINK? - 5newsonline.com•DaRe family establishes St. Luke’s first endowed chair for medical education - Bucks County Herald newspaper•TUFTS MEDICINE AND BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ANNOUNCE COLLABORATION TO EXPAND ACCESS TO CARE AND STREAMLINE PRIOR AUTHORIZATION - Blue Cross Blue Shield of Massachusetts•China Takes Cleantech Tariff Fight to COP31 Climate Summit - Impakter•Why Iyer believes Dhir gives India 'a lot of options' - Rediff•Club sports offer connection beyond competition - The Daily Toreador•Meta Boosts AI Investment to $135 Billion as Revenue Exceeds Expectations - 조선일보•Earnings call transcript: Graco posts record Q3 2026 sales, but shares fall sharply - Investing.com UK•IHG Says It’s Winning Hotels From Rival Brands•First human case of livestock virus Shamonda unlikely to lead to wider spread, WHO says - Reuters•Kratom Is an Opioid, Doctor Argues•Video Decision Aid Boosts Advance Care Planning in Late-Stage Kidney Disease•Milestone Moment With Grupo Duelo | Billboard Latin Music Week 2026•Forest Hills Stadium Agrees to Cap Number of Concerts Per Year, Ending Years of Litigation With Locals•James Bond Final Screen Tests Are Happening This Week•‘Tangles’ Wins Grand Jury Prize at Animation Is Film Festival•Telangana to host three-day Raksha Expo from December 7•Kerala High Court upholds 10-year jail term for man convicted of raping 73-year-old woman•Tirupati MP alleges NDA ‘coercion’ against YSRCP nominees, seeks SEC action•Kering’s revenues hit by drop in sales at flagship brand Gucci•BREAKING: Alabama Crimson Tide LOSING Key Players at WORST TIME—Is the SEASON ON THE BRINK? - 5newsonline.com•DaRe family establishes St. Luke’s first endowed chair for medical education - Bucks County Herald newspaper•TUFTS MEDICINE AND BLUE CROSS BLUE SHIELD OF MASSACHUSETTS ANNOUNCE COLLABORATION TO EXPAND ACCESS TO CARE AND STREAMLINE PRIOR AUTHORIZATION - Blue Cross Blue Shield of Massachusetts•China Takes Cleantech Tariff Fight to COP31 Climate Summit - Impakter•Why Iyer believes Dhir gives India 'a lot of options' - Rediff•Club sports offer connection beyond competition - The Daily Toreador•Meta Boosts AI Investment to $135 Billion as Revenue Exceeds Expectations - 조선일보•Earnings call transcript: Graco posts record Q3 2026 sales, but shares fall sharply - Investing.com UK
TheNewsPulse.pro
Home/clinical trials/diseases/drugs
clinical_trials

Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

Confidence95·multiple reportsImportance97NP-EVT-20261022-8EDD73D

Nature Medicine, Published online: 22 October 2026; doi:10.1038/s41591-026-04750-7 Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer

Read the original at the primary source
Author Correction: β-catenin confers resistance to PI3K and AKT inhibitors and subverts FOXO3a to promote metastasis in colon cancer
Héctor G. Palmer · 10/22/2026, 12:00:00 AM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse

Discussion

ChatsPulse · 0 threads

No discussion yet. Sign in and start the first thread —